1
A COMPARATIVE STUDY BETWEEN 1MG AND 3 MG OF GRANISETRON IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING IN STRABISMUS OPHTHALMIC SURGERIES DURING GENERAL ANESTHESIA
Condition(s):1mg Vs 3 mg of GranisetronLast Updated:June 21, 2021Completed
Granisetron as an Intervention: 120 Clinical Trials, Page 1 of 12
Hide Studies Not Open or Pending
2
Granisetron Transdermal Patch for Prevention of Postoperative Nausea and Vomiting
Condition(s):Postoperative Nausea and VomitingLast Updated:December 18, 2019Completed
3
Granisetron Transdermal Patch for Prophylaxis of Nausea and Vomiting in Patients Receiving Oral Anticancer Agents
Condition(s):Chemotherapy-induced Nausea and Vomiting (CINV)Last Updated:April 20, 2022Recruiting
4
Effect of Granisetron on Usage of Sympathomimetics During Caesarean Section
Condition(s):Hypotension; Cesarean Section ComplicationsLast Updated:May 16, 2018Completed
5
Granisetron in Diabetic Parturients Decrease Spinal Induced Hypotension
Condition(s):Spinal-induced HypotensionLast Updated:June 9, 2022Completed
6
Granisetron Transdermal Patch System for Prevention of CINV by CapeOX
Condition(s):Chemotherapy-induced Nausea and VomitingLast Updated:April 13, 2022Recruiting
7
Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis
Condition(s):GastroparesisLast Updated:February 14, 2022Withdrawn
8
Randomized Crossover Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Granisetron in Cancer Patients
Condition(s):VomitingLast Updated:January 27, 2015Completed
9
PK, Tolerability and Safety of the co-Administration of Sancuso® (Transdermal Granisetron) and IV Granisetron
Condition(s):HealthyLast Updated:May 4, 2009Completed
10
Role of Granisetron in Preventing Hypotension After Spinal Anesthesia With Levobupivacaine in Rheumatic Patients Undergoing Elective Cesarean Section
Condition(s):GranisetronLast Updated:April 6, 2022Recruiting